In announcing opioid settlement, $CVS CEO says the company has agreed to pay $5B over the next 10 years starting in 2023 to state and tribes, to" "put a decade old issue behind us."
Follow
Anjalee Khemlani
@AnjKhem
Anjalee Khemlani’s Tweets
Reports: CVS, Walgreens And Walmart Agree To $12 Billion Global Opioid Settlement forbes.com/sites/brucejap via
2
4
Breaking: CVS has agreed to pay about $5 billion to settle a raft of lawsuits over the nation’s opioid crisis. CVS said the deal wasn’t an admission of guilt, reports.
2
1
"We need infectious disease diplomacy," 's Ian Lipkin said. “We have to create a culture in which people want to share data with one another.”
Another must read from .
5
6
9
The enrollment season for Affordable Care Act health plans opens today, and more people are now eligible for them, reports
2
Top earners at Quest Diagnostics to pay higher insurance premiums: outgoing CEO $DGX
Quote Tweet
$PFE stock boosted amid a Q3 earnings beat and steady vaccine demand.
Pfizer’s “early look is positive, they’re going to be applying for regulatory approval by the end of the year,” @AnjKhem says on an RSV vaccine for pregnant mothers.
3:04
3.6K views
2
5
16
Show this thread
More info here
2
22
48
Show this thread
RSV vaccine news: Pfizer reporting positive readout of Phase 3 trial. Plans to submit for regulatory approval by end of 2022. $PFE
12
64
313
Show this thread
From the : Walensky experiencing rebound symptoms and tested positive for Covid-19 again after completing a course of Paxlovid.
101
349
834
Apparently, the latest conspiracy is "where is Walensky" if her illness is mild.
Google news can be sorted by date, folks.
She's been doing zoom presentations, promoting boosters.
I criticize CDC policies all the time, but can we stick to basic facts?
cbs19news.com/story/47575546
20
27
186
Show this thread
Rival drugmakers want to upend Pfizer’s dominance of the $7 billion worldwide market for pneumonia vaccines. on a big battle in big pharma.
1
1
"The American people have been presented with a false dichotomy: the diligent promotion of masks and vaccines, or a kind of resignation—saying 'you do you' ... even claiming that the pandemic is over," writes :
9
15
55
Flu season has hit 13-year record in US, CDC reports
3
9
12
New US Covid genomics: BQ.1.1 and BQ.1 variants now account for 27% of cases, up from 17% a week ago, on a path to be dominant (>50%) in the weeks ahead
covid.cdc.gov/covid-data-tra
25
312
749
Show this thread
Old: Should I move to Canada?
New: Should I stay on Twitter?
4
6
63
$ABBV earnings offer a fresh reminder that the US is spending more than 8x what the rest of the world combined is on adalimumab
3
6
23
The Problem With Our Boost-Boost-Boost COVID Strategy:
We need to explore more options for fighting the disease, but our leaders lack moral imagination.
By me for
theatlantic.com/ideas/archive/
11
42
108
Local shopping area posts “no masks allowed” sign
Neglects to specify they meant *Halloween* masks
Chaos ensues
via
popville.com/2022/10/wharf-
6
45
139
#NewOnKHN: In the past decade, private equity has moved aggressively into health care, gobbling up physician practices and even entire hospitals. But what exactly is private equity? KHN explains.
📹: and
21
14
New: Amid signs of accelerating health care inflation, health insurance is already frigging expensive. The average family premium for employer-provided health coverage reached $22,463 this year.
kff.org/private-insura
4
26
23
Show this thread
Breaking: Longtime Chairman Ken Frazier plans to leave Merck’s board, handing the job to his successor as chief executive, Rob Davis, reports
3
2
Administration officials told The Post they’re bracing for 30,000 to 70,000 preventable deaths from covid this winter.
Public health experts say that’s why admin must go further to save lives.
Our deep dive into the new “fall strategy” + what shaped it.
79
307
353
Top 15 drugs by sales in the US over the last decade.
Data from our annual forecast paper leveraging data.
Link: pubmed.ncbi.nlm.nih.gov/35385103/
#drugpolicy #dataviz #drugprices
0:30
2.9K views
1
32
61
Show this thread
A growing number of pharma companies are directing patients straight to online docs that can prescribe their drugs—a model that falls into a kind of regulatory limbo, some health law experts say.
Asks one: “Who’s minding the store here?”
1
14
17
At White House briefing, warns on rise of covid variants + says more $$ needed.
JHA: Some of the main tools we've had to protect the immunocompromised, like Evusheld, may not work moving forward. That's a huge challenge… [the] medicine cabinet has actually shrunk.
0:56
80.9K views
156
413
848
Show this thread
NEW HHS tv, print, and radio ads are debuting in 30 markets across the country this week targeting the Black, Latino, rural, and AAPI - high risk and historically underserved communities - to encourage vaccination ahead of winter.
1
7
9
Centene Reports $738 Million Profit And Picks Cigna’s Express Scripts As PBM forbes.com/sites/brucejap via
2
2
U.S. appeals court temporarily halts the Biden administration’s student loan forgiveness program
1
2
1
Quick math:
$19.50-$30 for 330M market
$110-$130 for half that (Bourla said expects flu-like market size)
Quote Tweet
$PFE COVID-19 vaccine prices are expected to hike as high as $130 per dose.
“It’s going to be borne by insurers, and so most Americans won’t be impacted by this price shift,” @AnjKhem says. “Pfizer did note that the uninsured will be taken care of.”
5:01
3.3K views
3
5
11
Pfizer's plan to as much as quadruple U.S. prices for its COVID-19 vaccine next year is beyond Wall Street's expectations and will spur its revenue for years despite weaker than anticipated demand for the new booster shot so far, analysts said.
6
6
Rich countries are destroying covid vaccines they hoarded while much of the world still waits for their first shot
6
2
15
FDA’s Peter Marks anticipates moving to a bivalent primary series, pending data expected the next few months (currently only boosters are bivalent). He says that FDA will convene its advisory committee, possibly early next year, for these discussions.
5
12
17
Fights about the ACA are completely missing from campaign debates this election cycle, marking the first time in more than 10 years it’s not been at the forefront of the election conversation.
First co-byline w/ for
2
17
37
